| BDX |
Report |
Fiscal 3Q26 adjusted EPS |
BEAT |
pred ~$3.19 vs. cons $3.14 |
MEDIUM |
| BDX |
Report |
Fiscal 3Q26 FX-neutral revenue growth |
BEAT |
pred ~2.8% vs. cons 2.6% |
MEDIUM |
| BDX |
Report |
Fiscal 3Q26 adjusted operating margin |
IN-LINE |
pred ~25.3% vs. cons 25.1% |
LOW |
| BDX |
Guide |
Adjusted EPS guidance |
BETTER |
guide ~$12.70 midpoint vs. cons $12.66 (FY26) |
MEDIUM |
| BDX |
Guide |
FX-neutral revenue-growth guidance |
BETTER |
guide ~2.7% vs. cons 2.6% (FY26) |
LOW |
| BDX |
Guide |
Adjusted operating-margin guidance |
UNCHANGED |
guide ~25.0% vs. cons 25.0% (FY26) |
MEDIUM |
| BDX |
Guide |
FX-neutral revenue-growth commentary |
LOWER |
guide ~2.7% vs. cons 3.1% (FY27) |
MEDIUM |
| BDX |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.8% |
— |
LOW |
| BDX |
Return |
5-day cumulative residual |
-1.5% (FADE) |
A modest reported beat and small FY26 EPS increase support the initial reaction, but an implied FY27 FX-neutral growth outlook of ~2.7% versus consensus 3.1% drives out-period estimate cuts as the Alaris headwind rises to roughly 200 basis points, causing the beat-driven gain to fade. |
MEDIUM |